pyrazole has been researched along with Lung Diseases in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pre-treatment with pyrazole, which exacerbated BHT-induced lung injury, did not affect pulmonary coumarin hydroxylase or 4-nitrophenol hydroxylase activity but increased that of PROD." | 1.30 | Selective inhibition and induction of CYP activity discriminates between the isoforms responsible for the activation of butylated hydroxytoluene and naphthalene in mouse lung. ( Dinsdale, D; Martin, J; Verschoyle, RD, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verschoyle, RD | 1 |
| Martin, J | 1 |
| Dinsdale, D | 1 |
1 other study available for pyrazole and Lung Diseases
| Article | Year |
|---|---|
Selective inhibition and induction of CYP activity discriminates between the isoforms responsible for the activation of butylated hydroxytoluene and naphthalene in mouse lung.
Topics: Animals; Biotransformation; Body Weight; Butylated Hydroxytoluene; Cytochrome P-450 CYP2B1; Cytochro | 1997 |